Erin W. Meermeier
- Immunology top 5%
- Immune Cell Function and Interaction 12
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 4
- Infectious Diseases top 5%
- Epidemiology top 10%
- Cytomegalovirus and herpesvirus research 5
- Virology top 10%
- Hematology top 10%
- Multiple Myeloma Research and Treatments 11
-
- Protein Degradation and Inhibitors 7
-
- CAR-T cell therapy research 4
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- David LewinsohnDavid W. DowdyDavid R. ShermanKogieleum NaidooKristina L. BajemaPaul K. DrainKeertan DhedaShuyi Ma
- Partner nations
- United StatesUnited KingdomSouth Africa
In The Last Decade
Erin W. Meermeier
28 papers receiving 924 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Immunology 436
- Infectious Diseases 364
- Epidemiology 357
- Virology 47
- Hematology 72
Countries citing papers authored by Erin W. Meermeier
This map shows the geographic impact of Erin W. Meermeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin W. Meermeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin W. Meermeier more than expected).
Fields of papers citing papers by Erin W. Meermeier
This network shows the impact of papers produced by Erin W. Meermeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin W. Meermeier. The network helps show where Erin W. Meermeier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erin W. Meermeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 21 | |
| 9 | 2021 | 67 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 15 | |
| 14 | 2019 | 47 | |
| 15 | 2019 | 1 | |
| 16 | 2019 | 24 | |
| 17 | 2018 | 93 | |
| 18 | 2016 | 94 | |
| 19 | 2015 | 31 | |
| 20 | 2014 | 42 |
About Erin W. Meermeier
Erin W. Meermeier is a scholar working on Hematology, Immunology and Endocrinology, having authored 29 papers that have together received 935 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Multiple Myeloma Research and Treatments (11 papers), Protein Degradation and Inhibitors (7 papers), T-cell and B-cell Immunology (6 papers), Cytomegalovirus and herpesvirus research (5 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Immunology (436 citations), Infectious Diseases (364 citations) and Epidemiology (357 citations). Erin W. Meermeier has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include David Lewinsohn, David W. Dowdy, David R. Sherman, Kogieleum Naidoo, Kristina L. Bajema, Paul K. Drain, Keertan Dheda, Shuyi Ma, Samuel G. Schumacher and Melanie J. Harriff. Their work appears in journals such as Blood, Nature Communications, The Journal of Immunology, PLoS Pathogens and Immunology and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.